PFE
Price:
$25.65
Market Cap:
$145.36B
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disea...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
PFE
According to Pfizer Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 34.20. This represents a change of -91.83% compared to the average of 418.80 of the last 4 quarters.
The mean historical PE Ratio of Pfizer Inc. over the last ten years is 24.78. The current 34.20 PE Ratio has changed 13.70% with respect to the historical average. Over the past ten years (40 quarters), PFE's PE Ratio was at its highest in in the June 2024 quarter at 1.67K. The PE Ratio was at its lowest in in the December 2015 quarter at -274.60.
Average
24.78
Median
21.15
Minimum
9.16
Maximum
76.67
Discovering the peaks and valleys of Pfizer Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 737.04%
Maximum Annual PE Ratio = 76.67
Minimum Annual Increase = -62.98%
Minimum Annual PE Ratio = 9.16
Year | PE Ratio | Change |
---|---|---|
2023 | 76.67 | 737.04% |
2022 | 9.16 | -39.13% |
2021 | 15.05 | -48.34% |
2020 | 29.13 | 129.17% |
2019 | 12.71 | -41.66% |
2018 | 21.79 | 126.51% |
2017 | 9.62 | -62.98% |
2016 | 25.98 | -4.30% |
2015 | 27.15 | 32.36% |
2014 | 20.51 | 128.14% |
The current PE Ratio of Pfizer Inc. (PFE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
33.63
5-year avg
28.54
10-year avg
24.78
Pfizer Inc.’s PE Ratio is less than AbbVie Inc. (61.11), greater than Merck & Co., Inc. (20.67), less than Eli Lilly and Company (80.52), greater than Bristol-Myers Squibb Company (-16.45), greater than Johnson & Johnson (25.44), less than Amgen Inc. (37.39), less than Gilead Sciences, Inc. (892.59),
Company | PE Ratio | Market cap |
---|---|---|
61.11 | $312.70B | |
20.67 | $250.89B | |
80.52 | $710.10B | |
-16.45 | $119.40B | |
25.44 | $373.59B | |
37.39 | $158.32B | |
892.59 | $112.40B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pfizer Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pfizer Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pfizer Inc.'s PE Ratio?
How is the PE Ratio calculated for Pfizer Inc. (PFE)?
What is the highest PE Ratio for Pfizer Inc. (PFE)?
What is the 3-year average PE Ratio for Pfizer Inc. (PFE)?
What is the 5-year average PE Ratio for Pfizer Inc. (PFE)?
How does the current PE Ratio for Pfizer Inc. (PFE) compare to its historical average?